Search - tctmd.com

Displaying 181 - 200 of 488

Sort: Relevancy | Date

Presentation ESC 2019

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

Presenter: David B. Brieger

September 01, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Michael O'Riordan

August 31, 2019

News Conference News ESC 2019

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

Yael L. Maxwell

August 31, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Conference News SCCT 2019

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Yael L. Maxwell

July 18, 2019

News Conference News EuroPCR 2019

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Caitlin E. Cox

June 05, 2019

News Conference News EAS 2019

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

Michael O'Riordan

June 04, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

Taking Ticagrelor? Frank, Proactive Patient Conversations are Needed to Help With Adherence

News Daily News

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Yael L. Maxwell

May 17, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Industry News

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

May 13, 2019

News Daily News

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

Michael O'Riordan

April 15, 2019

News Daily News

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Todd Neale

April 10, 2019

News Features

Top News in Coronary Artery Disease: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

L.A. McKeown

November 29, 2018

News Conference News ESC 2018

Myocardial Injury or MI? New Universal Definition Aims for Clarity

Todd Neale

September 05, 2018

News Conference News ESC 2018

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

Todd Neale

September 04, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

Advertisement

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

POPULAR AGE Supports Clopidogrel Over Ticagrelor in Elderly ACS Patients

Evolocumab in Acute ACS Safely Reduces LDL Cholesterol: EVOPACS

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Doubling Down on SCOT-HEART: Mechanisms, Applicability, and Future Directions

Cardiogenic Shock Old and New: IABPs a Thing of the Past and ECMO Under Study

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Taking Ticagrelor? Frank, Proactive Conversations are Needed to Help With Adherence

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy

Most STEMI Patients Head to ICU After PCI, but Not All Need to Go

There’s No ‘I’ in Shock Team: Multidisciplinary Approach Seems to Pay Dividends

Top News in Coronary Artery Disease: 2018

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

Myocardial Injury or MI? New Universal Definition Aims for Clarity

Latest SWEDEHEART Data Show Acute MI Mortality Rates Have Stagnated

TCTMD’s Top 10 Most Popular Stories for August 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content